Developing a vaccine against Nipah virus

(Thomas Jefferson University) Researchers developed a novel recombinant vaccine called NIPRAB that shows robust immunization against Nipah virus in animal models and may be effective against other viruses in the same family.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news

Related Links:

Nipah virus is an emerging pathogenic paramyxovirus responsible for sporadic and isolated outbreaks of severe respiratory and neurologic disease in Southern Asia. As a zoonotic virus, disease can manifest in both animals and human with indigenous fruit bats acting as natural reservoirs of the virus. The effects of viral infection vary from acute respiratory distress to fatal encephalitis. There are currently no approved therapeutics or vaccines against the virus, and growing concerns that this highly pathogenic infection has the potential to cause larger epidemics capable of inflicting significant mortality burden.Like the...
Source: NIH OTT Licensing Opportunities - Category: Research Authors: Source Type: research
by Neeltje van Doremalen, Teresa Lambe, Sarah Sebastian, Trenton Bushmaker, Robert Fischer, Friederike Feldmann, Elaine Haddock, Michael Letko, Victoria A. Avanzato, Ilona Rissanen, Rachel LaCasse, Dana Scott, Thomas A. Bowden, Sarah Gilbert, Vincent Munster Nipah virus (NiV) is a highly pathogenic re-emerging virus that causes outbreaks in South East Asia. Currently, no approved and licensed vaccine or antivirals exist. Here, we investigated the efficacy of ChAdOx1 NiVB, a simian adenovirus-based vaccine encoding NiV glycoprotein (G) Bangladesh, in Syrian hamsters. Prime-only as well as prime-boost vaccination resulted i...
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Source Type: research
Authors: Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, Munjal A, Vora KS, Latheef SK, Karthik K, Singh Malik Y, Singh R, Chaicumpa W, Mourya DT Abstract Nipah (Nee-pa) viral disease is a zoonotic infection caused by Nipah virus (NiV), a paramyxovirus belonging to the genus Henipavirus of the family Paramyxoviridae. It is a biosafety level-4 pathogen, which is transmitted by specific types of fruit bats, mainly Pteropus spp. which are natural reservoir host. The disease was reported for the first time from the Kampung Sungai Nipah village of Malaysia in 1998. Human-to-human transmission also occu...
Source: Veterinary Quarterly - Category: Veterinary Research Tags: Vet Q Source Type: research
Purpose: Nipah virus (NiV), a paramyxovirus, causes febrile encephalitis and severe respiratory disease in humans and animals. Nipah virus outbreaks have been reported from Malaysia, Bangladesh, India and Singapore. The case positive in humans have been attributed to zoonotic transmission from pigs and bats, human-to-human transmission, and eating fruits or juices contaminated with bat secretions. At present no vaccines or drugs are available for those infected with NiV. Fruit bats of family Pteropodidae have been identified as the reservoir for NiV.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: 20.066 Source Type: research
AbstractPurpose of ReviewThe review summarizes the history of the emergence of the Henipviruses, provides a general introduction of their molecular biology and the efforts to develop antiviral treatment strategies, including the successful development of a veterinary vaccine.Recent FindingsParamyxoviridae, genusHenipavirus comprises emerging pathogens detected in Southeast Asia, Australia and Africa. Henipaviruses are enveloped with non-segmented, negative-sense, single-stranded RNA molecules and are distinguished from other Paramyxoviruses by a substantially larger RNA genome. Hendra virus (HeV) and Nipah virus (NiV) are ...
Source: Current Treatment Options in Infectious Diseases - Category: Infectious Diseases Source Type: research
Lassa, Mers and Nipah will be first diseases targeted by programme announced at Davos by coalition of governments, philanthropists and businessA coalition of governments, philanthropists and business is pledging to put money and effort into making vaccines to stop the spread of diseases that could threaten mankind – and to prevent another outbreak as devastating as the Ebola epidemic.At theWorld Economic Forum in Davos, the Norwegian, Japanese and German governments, the Wellcome Trust and the Gates Foundation announced they were putting in $460 million – half of what is needed for the first five years of the i...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Vaccines and immunisation Infectious diseases Davos Health Epidemics Medical research Business Science Society World news Source Type: news
In conclusion, both humoral and cellular immune responses were required for protection of swine against henipaviruses. PMID: 27544586 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
Zika virus, Ebola, Middle East Respiratory Syndrome (MERS) coronavirus, Severe Acute Respiratory Syndrome (SARS) coronavirus, Nipah virus, Hendra virus, bird flu, swine flu -- these viruses have all grabbed international attention in recent years. In the past few decades the world has witnessed an alarming surge in emerging infectious diseases (EIDs). Since 1980, new pathogens have emerged in the human population at a rate of about three each year. Why are we seeing such a surge in new pathogens? One could argue that some of the pathogens may not be new at all; they could have circulated among humans for centuries and are...
Source: Science - The Huffington Post - Category: Science Source Type: news
CONCLUSIONS: Polyclonal antibodies have been successfully applied to rabies, envenomation and intoxication. Polyclonal production provides an exciting opportunity to revolutionise the prognosis of both longstanding neglected tropical diseases as well as emerging infectious threats to humans. PMID: 26802604 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
Abstract The genus Henipavirus within the family Paramyxoviridae includes the Hendra virus (HeV) and Nipah virus (NiV) which were discovered in the 1990s in Australia and Malaysia, respectively, after emerging to cause severe and often fatal outbreaks in humans and animals. While HeV is confined to Australia, more recent NiV outbreaks have been reported in Bangladesh, India and the Philippines. The clinical manifestations of both henipaviruses in humans appear similar, with a predominance of an acute encephalitic syndrome. Likewise, the pathological features are similar and characterized by disseminated, multi‐organ vasc...
Source: Brain Pathology - Category: Neurology Authors: Tags: Mini‐Symposium: Emerging Viral Infections of the Central Nervous System Source Type: research
More News: Infectious Diseases | Nipah Virus | Vaccines | Veterinary Vaccinations